A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2015 by AbbVie
United States Oncology
NSABP Foundation Inc
Alliance for Clinical Trials in Oncology
German Breast Group
Grupo Espanol de Investigacion del Cancer de Mama
Information provided by (Responsible Party):
ClinicalTrials.gov Identifier:
First received: December 13, 2013
Last updated: October 9, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)